- Home
- CLDX vs MMI Comparison
CLDX vs MMI Comparison
Compare CLDX & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- MMI
- Stock Information
- Founded
- CLDX N/A
- MMI 1971
- Country
- CLDX United States
- MMI United States
- Employees
- CLDX N/A
- MMI N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MMI Real Estate
- Sector
- CLDX Health Care
- MMI Finance
- Exchange
- CLDX Nasdaq
- MMI Nasdaq
- Market Cap
- CLDX 1.3B
- MMI 1.1B
- IPO Year
- CLDX 2008
- MMI 2013
- Fundamental
- Price
- CLDX $21.35
- MMI $29.72
- Analyst Decision
- CLDX Buy
- MMI Sell
- Analyst Count
- CLDX 9
- MMI 1
- Target Price
- CLDX $50.00
- MMI $30.00
- AVG Volume (30 Days)
- CLDX 1.0M
- MMI 141.1K
- Earning Date
- CLDX 08-07-2025
- MMI 05-07-2025
- Dividend Yield
- CLDX N/A
- MMI 1.68%
- EPS Growth
- CLDX N/A
- MMI N/A
- EPS
- CLDX N/A
- MMI N/A
- Revenue
- CLDX $7,559,000.00
- MMI $711,994,000.00
- Revenue This Year
- CLDX N/A
- MMI $11.69
- Revenue Next Year
- CLDX N/A
- MMI $24.07
- P/E Ratio
- CLDX N/A
- MMI N/A
- Revenue Growth
- CLDX 24.49
- MMI 14.79
- 52 Week Low
- CLDX $14.40
- MMI $27.61
- 52 Week High
- CLDX $47.00
- MMI $42.80
- Technical
- Relative Strength Index (RSI)
- CLDX 59.74
- MMI 50.35
- Support Level
- CLDX $19.25
- MMI $29.22
- Resistance Level
- CLDX $20.56
- MMI $30.47
- Average True Range (ATR)
- CLDX 1.13
- MMI 0.77
- MACD
- CLDX 0.04
- MMI 0.24
- Stochastic Oscillator
- CLDX 97.22
- MMI 73.78
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About MMI Marcus & Millichap Inc.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.